Cinctive Capital Management LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cinctive Capital Management LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$12,486,377
+151.5%
139,388
+139.1%
0.62%
+272.3%
Q2 2023$4,963,832
-65.7%
58,302
-66.7%
0.17%
-65.6%
Q1 2023$14,491,594
+161.4%
175,125
+148.4%
0.48%
+77.9%
Q4 2022$5,544,039
-53.3%
70,490
-56.1%
0.27%
-45.5%
Q3 2022$11,884,000
+209.7%
160,526
+195.4%
0.50%
+164.4%
Q3 2021$3,837,000
+265.4%
54,351
+244.9%
0.19%
+283.7%
Q2 2021$1,050,000
-76.6%
15,759
-58.2%
0.05%
-86.6%
Q4 2020$4,481,000
+143.5%
37,733
+79.0%
0.36%
+126.7%
Q3 2020$1,840,00021,0840.16%
Other shareholders
HAEMONETICS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders